Literature DB >> 29904717

Measurement bone mineral density (BMD) of patients with beta thalassemia.

Sakineh Abbasi1, Jafar Fatahi Asl2, Leila Moein Zadeh3, Mohammad Mirdoraghi4.   

Abstract

The aim of the study is determining bone mineral density (BMD) of Patients with beta thalassemia in order to find the prevalence and related factors on the conditions. Z-Score of femoral neck and lumbar vertebrae were reported comparing normal matched subjects. Age and bone mineral density were significantly correlated. Moreover, the disease had significantly higher severity in men than in women. A negative significant correlation was detected between BMD and the mean of hematocrit in the last 5 years. There was significant differences between sex hormone and bone density. A significant correlation between hydroxy urea and BMD were found. A significant relationship between the use of bisphosphonates and bone density were found. Osteopenia and osteoporosis were highly prevalent in our participants. Therefore, regular tests are required to examine bone mineral density in these patients. Furthermore, the exact effect of age on bone mineral density need to be clarified.

Entities:  

Keywords:  Ahvaz; Beta thalassemia; Bone mineral density; Osteoporosis; Z-Score

Year:  2018        PMID: 29904717      PMCID: PMC5998177          DOI: 10.1016/j.dib.2018.05.120

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications Table Value of the data This study showed bone mineral density reduced with increasing age (p<0.03). Measured BMD had a better status in the femoral region than in the lumbar region. Since the patients were in puberty, there was a significant correlation between the use of sex hormones and BMD. The bone mineral density increased in patients who taking bisphosphonates.

Data

The participants included 81 male and 103 female patients with transfusion-dependent thalassemia (β-thalassemia). As seen in Table 1, the mean age of the participants was 23.4±8.0 years (range: 15–31 years). Based on the Z-scores at the lumbar spine, 198 patients (82%) had low BMD (Z ≤−2) and 40 (18%) had normal BMD (Z ≥−1). Meanwhile, low BMD in the neck of the femur was only seen in 18% of the participants. A significant correlation between age and bone mineral density were found (P<0.03). Per year to 2.8 percent of bone mineral density scores are low. The severity of the disease was higher in men than in women (P<00.02). A negative significant correlation was detected between BMD and the mean of hematocrit in the last 5 years (P<0.005). There was significant differences between Sex hormone and bone density (P<0.02). The significant relationship between Hydroxyl urea consumption and bone mineral density was seen (P<00.01). A significant relationship between the use of bisphosphonates and bone density exists so that the bone mineral density in patients taking bisphosphonates have been increased (P<0.02). The patients who used calcium+vitamin D had no significant difference with the others in terms of BMD. Moreover, no significant correlation was found between the use of calcitriol and BMD.
Table 1

Demographic features of patients (confidence interval=95%).

Demographic features of patientsTime consuming(year)
Calcium+Vitamin D of consuming time to first measurement1/8±2/4
Calcium+Vitamin D of consuming time to the second measurement time6/3±3
Calcium+Vitamin D starting age22±7
Age of onset of sex hormones15±6
Duration of sex hormones to first measure6/3±4
Duration of sex hormones to the second measure9/6±3
Age of onset of Calcitriol21±7
Calcitriol duration of the first measure2±3
Calcitriol use to measure a second time6±3
Age starting bisphosphonate22±7
bisphosphonate use to measure of the first time1±2
bisphosphonate use to measure a second time2/3±2
Age starting hydroxyurea16/5±6
hydroxyurea use to measure of the first time5/9±3/6
hydroxyurea use to measure a second time6/2±3/2
Demographic features of patients (confidence interval=95%).

Experimental design, materials and methods

A total of 216 patients (age>15 years) with transfusion-dependent thalassemia who visited Shafa Hospital (Ahwaz, Iran) participated in this prospective study. Their BMD had been annually monitored from age 10. The bone density in 216 patients (81 males and 103 females) who are suffering from thalassemia major, by Dual-Energy X-ray Absorptiometry. (Manufactured by Lunar company of USA) to be measured [1], [2]. The patients׳ demographic characteristics, average five-year hematocrit level (2008–2013), and history of medications were extracted from their records. DEXA was then performed twice to measure BMD in the femur and lumbar region [3], [4]. To reduce measurement errors in each region measured three times mineral density and an average is taken (Table 2).
Table 2

The average of Z-Score before and after intake of drug (confidence interval=95%).

Demographic features of patientsThe average of Z-Score in the first timeThe average of Z-Score in the second timeP-value
Calcium+Vitamin D−2/33±0/78–2/43±0/97P>0.05
sex hormones−2/41±0/26−1/91±0/11P<0.02
Calcitriol duration−1/44±0/18−1/98±0/36P>0.05
bisphosphonate−2/45±0/88−1/88±0/22P<0.02
Hydroxy urea use to measure of the first time−2/59±0/96−2/50±0/24P<00.01
The average of Z-Score before and after intake of drug (confidence interval=95%). To view the impact of drugs on patients before and after drug consumption Z and T score were measured before and after drug consumption. In measuring the density by Dual-Energy X-ray Absorptiometry each person has three criteria: first index (Z): actually indicates Compare between patient׳s bone density and bone density persons are same age and gender. The second index (T): the comparison between the patient׳s bone density and bone density persons are same age [5], [6], [7]. Z-scores were obtained from BMD measurements and used to decide whether the patients had osteopenia or osteoporosis. Data analysis was performed with software SPSS 20 and the effect of drugs was studied by Wilcoxon test.
Subject areaMedical Physics
More specific subject areaDescribe the bone mineral density (BMD) of patients with beta thalassemia
Type of dataTables
How data was acquiredTo calculate the bone mineral density, All medical records of patients older than 15 years were reviewed. Patients demography were extracted, the results of the BMD and Z-Score of femoral neck and lumbar vertebrae were reported comparing normal matched subjects. Z-Scores <−1, −1 to −2.5, and bigger than −2.5 were considered as Normal, osteopenia and osteoporotic respectively.
Data formatRaw, Analyzed
Experimental factorsThe mentioned parameters above, in abstract section, were analyzed according to the standards for Z-Score.
Experimental featuresThe Z-Scores were determined.
Data source locationAhvaz province, Iran.
Data accessibilityThe data are available whit this article
  6 in total

1.  Bone mineral density in beta-thalassemia major and intermedia.

Authors:  Mehran Karimi; Alireza Fotouhi Ghiam; Alireza Hashemi; Saied Alinejad; Mahmood Soweid; Sara Kashef
Journal:  Indian Pediatr       Date:  2007-01       Impact factor: 1.411

2.  Cervical spine bone density in young healthy adults as a function of sex, vertebral level and anatomic location.

Authors:  William J Anderst; Tyler West; William F Donaldson; Joon Y Lee
Journal:  Eur Spine J       Date:  2017-05-06       Impact factor: 3.134

3.  Prevalence of low bone mass among adolescents with nontransfusion-dependent hemoglobin E/β-thalassemia and its relationship with anemia severity.

Authors:  Pairunyar Nakavachara; Jaturat Petchkul; Krittha Jeerawongpanich; Pornpimol Kiattisakthavee; Teerarat Manpayak; Parichat Netsakulnee; Katharee Chaichanwattanakul; Julaporn Pooliam; Somdet Srichairatanakool; Vip Viprakasit
Journal:  Pediatr Blood Cancer       Date:  2017-08-12       Impact factor: 3.167

4.  Summary and Review of the Abstracts on Disorders of Red Cells and Erythropoiesis Presented at Haematocon 2016-2017.

Authors:  Prashant Sharma
Journal:  Indian J Hematol Blood Transfus       Date:  2017-12-26       Impact factor: 0.900

5.  Bone-density testing interval and transition to osteoporosis in patients with rheumatoid arthritis.

Authors:  J Hwang; E-K Lee; J K Ahn; H-S Cha; E-M Koh; J Lee
Journal:  Osteoporos Int       Date:  2016-08-10       Impact factor: 4.507

6.  Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study.

Authors:  Marco Atteritano; Stefania Sorbara; Gianluca Bagnato; Giovanni Miceli; Donatella Sangari; Salvatore Morgante; Elisa Visalli; Gianfilippo Bagnato
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

  6 in total
  2 in total

1.  Bone Mineral Density, Serum Calcium, and Vitamin D Levels in Adult Thalassemia Major Patients: Experience From a Single Center in Eastern India.

Authors:  Soumya Santra; Kunal Sharma; Ipsita Dash; Shaikat Mondal; Himel Mondal
Journal:  Cureus       Date:  2022-07-09

Review 2.  New Entity-Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement.

Authors:  Mara Carsote; Cristina Vasiliu; Alexandra Ioana Trandafir; Simona Elena Albu; Mihai-Cristian Dumitrascu; Adelina Popa; Claudia Mehedintu; Razvan-Cosmin Petca; Aida Petca; Florica Sandru
Journal:  Diagnostics (Basel)       Date:  2022-08-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.